BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 33015197)

  • 1. Analysis of Killer Cell Immunoglobulin-Like Receptor Genes and Their HLA Ligands in Inflammatory Bowel Diseases.
    Beigmohammadi F; Mahmoudi M; Karami J; Ahmadzadeh N; Ebrahimi-Daryani N; Rezaei N
    J Immunol Res; 2020; 2020():4873648. PubMed ID: 33015197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of killer cell immunoglobulin-like receptor (KIR) genes and human leukocyte antigen (HLA) class I ligands on predisposition or protection against prostate cancer.
    Roshan Zamir M; Ariafar A; Ghaderi A; Amirzargar A
    Immunobiology; 2023 Mar; 228(2):152319. PubMed ID: 36599262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between KIR-HLA combination and ulcerative colitis and Crohn's disease in a Japanese population.
    Saito H; Hirayama A; Umemura T; Joshita S; Mukawa K; Suga T; Tanaka E; Ota M
    PLoS One; 2018; 13(4):e0195778. PubMed ID: 29649328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes to Predict the Occurrence of Acute Allograft Rejection after Kidney Transplantation.
    Jafari D; Nafar M; Yekaninejad MS; Abdolvahabi R; Lesan Pezeshki M; Razaghi E; Amirzargar AA
    Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):245-255. PubMed ID: 28732438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Killer immunoglobulin-like receptor repertoire analysis in a Caucasian Spanish cohort with inflammatory bowel disease.
    López-Hernández R; Campillo JA; Legaz I; Valdés M; Salama H; Boix F; Hernández-Martínez AM; Eguia J; González-Martínez G; Moya-Quiles MR; Minguela A; García-Alonso A; Carballo F; Muro M
    Microbiol Immunol; 2016 Nov; 60(11):787-792. PubMed ID: 27797112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of killer cell immunoglobulin-like receptor (KIR) genes and their HLA ligands with susceptibility to Behçet's‎ disease.
    Mohammad-Ebrahim H; Kamali-Sarvestani E; Mahmoudi M; Beigy M; Karami J; Ahmadzadeh N; Shahram F
    Scand J Rheumatol; 2018 Mar; 47(2):155-163. PubMed ID: 28862099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Killer Cell Immunoglobulin-like Receptor Genes and Their HLA Ligands in Iranian Patients with Ankylosing Spondylitis.
    Mahmoudi M; Jamshidi AR; Karami J; Mohseni A; Amirzargar AA; Farhadi E; Ahmadzadeh N; Nicknam MH
    Iran J Allergy Asthma Immunol; 2016 Feb; 15(1):27-38. PubMed ID: 26996109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of killer cell immunoglobulin-like receptors (KIRs) and their HLA ligand genes polymorphisms in Iranian patients with systemic sclerosis.
    Mahmoudi M; Fallahian F; Sobhani S; Ghoroghi S; Jamshidi A; Poursani S; Dolati M; Hosseinpour Z; Gharibdoost F
    Clin Rheumatol; 2017 Apr; 36(4):853-862. PubMed ID: 28120169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of killer-cell immunoglobulin-like receptor (KIR) genes in susceptibility to inflammatory bowel disease: systematic review and meta-analysis.
    Fathollahi A; Aslani S; Mostafaei S; Rezaei N; Mahmoudi M
    Inflamm Res; 2018 Sep; 67(9):727-736. PubMed ID: 29869094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of killer cell immunoglobulin-like receptors and their cognate HLA class I ligands with susceptibility to acute myeloid leukemia in Iranian patients.
    Mirzazadeh S; Bemani P; Halimi H; Sanaee MN; Karami N; Ramzi M; Farjadian S
    Sci Rep; 2023 Jul; 13(1):11456. PubMed ID: 37454198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study.
    Varbanova VP; Mihailova S; Naumova E; Mihaylova AP
    Turk J Haematol; 2019 Nov; 36(4):238-246. PubMed ID: 31337191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of killer immunoglobulin-like receptor genes and human leukocyte antigens class I ligands in a Caucasian Brazilian population with Crohn's disease and ulcerative colitis.
    Wilson TJ; Jobim M; Jobim LF; Portela P; Salim PH; Rosito MA; Damin DC; Flores C; Peres A; Machado MB; Chies JA; Schwartsmann G; Roesler R
    Hum Immunol; 2010 Mar; 71(3):293-7. PubMed ID: 20036705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism of killer cell immunoglobulin-like receptors (KIR) and their HLA ligands in Graves' disease.
    Dastmalchi R; Farazmand A; Noshad S; Mozafari M; Mahmoudi M; Esteghamati A; Amirzargar A
    Mol Biol Rep; 2014 Aug; 41(8):5367-74. PubMed ID: 24852304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility to pulmonary tuberculosis in Iranian individuals is not affected by compound KIR/HLA genotype.
    Tajik N; Shah-hosseini A; Mohammadi A; Jafari M; Nasiri M; Radjabzadeh MF; Farnia P; Jalali A
    Tissue Antigens; 2012 Feb; 79(2):90-6. PubMed ID: 22128749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The investigation of killer-cell immunoglobulin-like receptors (KIRs) and their HLA ligands in Iranian patients with myasthenia gravis.
    Jalalvand M; Beigmohammadi F; Soltani S; Ehsan S; Rajabkhah S; Madreseh E; Akhtari M; Jamshidi A; Farhadi E; Mahmoudi M; Nafissi S
    Clin Neurol Neurosurg; 2024 Mar; 238():108171. PubMed ID: 38422742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imbalance of Genes Encoding Natural Killer Immunoglobulin-Like Receptors and Human Leukocyte Antigen in Patients With Biliary Cancer.
    Cornillet M; Jansson H; Schaffer M; Hertwig L; Berglin L; Zimmer CL; Johansson H; Ellis E; Isaksson B; Gonzalez-Galarza FF; Middleton D; Malmberg KJ; Sparrelid E; Björkström NK
    Gastroenterology; 2019 Oct; 157(4):1067-1080.e9. PubMed ID: 31229495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms of killer immunoglobulin-like receptors (KIRs) and HLA ligands in northeastern Thais.
    Chaisri S; Kitcharoen K; Romphruk AV; Romphruk A; Witt CS; Leelayuwat C
    Immunogenetics; 2013 Sep; 65(9):645-53. PubMed ID: 23812166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic profiles of killer-cell immunoglobulin-like receptors and HLA ligands in Thai blood donors.
    Kitpoka P; Tammakorn C; Chaisri S; Leelayuwat C; Mongkolsuk T; Thammanichanond D
    Hum Immunol; 2016 Jun; 77(6):470-5. PubMed ID: 27131859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of donor KIRs and recipient KIR/HLA class I combinations on GVHD in patients with acute leukemia after HLA-matched sibling HSCT.
    Mansouri M; Villard J; Ramzi M; Alavianmehr A; Farjadian S
    Hum Immunol; 2020 Jun; 81(6):285-292. PubMed ID: 32199702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of killer cell immunoglobulin-like receptors and their human leukocyte antigen-ligands gene polymorphisms in Iranian patients with systemic lupus erythematosus.
    Akhtari M; Farazmand A; Mahmoudi M; Akbarian M; Ahmadzadeh N; Mirkazemi Z; Mostafaei S; Jamshidi AR
    Lupus; 2016 Oct; 25(11):1244-53. PubMed ID: 26989167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.